nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCB1—colon cancer	0.387	1	CbGaD
Apixaban—ABCG2—Irinotecan—colon cancer	0.0729	0.133	CbGbCtD
Apixaban—ABCG2—Fluorouracil—colon cancer	0.0699	0.127	CbGbCtD
Apixaban—ABCG2—Vincristine—colon cancer	0.0637	0.116	CbGbCtD
Apixaban—CYP2C9—Capecitabine—colon cancer	0.0438	0.0798	CbGbCtD
Apixaban—CYP3A5—Irinotecan—colon cancer	0.0404	0.0735	CbGbCtD
Apixaban—ABCG2—Methotrexate—colon cancer	0.0386	0.0702	CbGbCtD
Apixaban—CYP2C8—Fluorouracil—colon cancer	0.0373	0.0678	CbGbCtD
Apixaban—CYP3A5—Vincristine—colon cancer	0.0353	0.0643	CbGbCtD
Apixaban—CYP1A2—Fluorouracil—colon cancer	0.0288	0.0525	CbGbCtD
Apixaban—ABCB1—Irinotecan—colon cancer	0.0263	0.0478	CbGbCtD
Apixaban—CYP2C9—Fluorouracil—colon cancer	0.026	0.0473	CbGbCtD
Apixaban—ABCB1—Vincristine—colon cancer	0.023	0.0418	CbGbCtD
Apixaban—CYP3A4—Irinotecan—colon cancer	0.0157	0.0287	CbGbCtD
Apixaban—ABCB1—Methotrexate—colon cancer	0.0139	0.0253	CbGbCtD
Apixaban—CYP3A4—Vincristine—colon cancer	0.0138	0.0251	CbGbCtD
Apixaban—Wound secretion—Capecitabine—colon cancer	0.00388	0.0756	CcSEcCtD
Apixaban—CYP2J2—blood vessel—colon cancer	0.00202	0.163	CbGeAlD
Apixaban—Cerebral haemorrhage—Vincristine—colon cancer	0.00156	0.0304	CcSEcCtD
Apixaban—Haematochezia—Capecitabine—colon cancer	0.0014	0.0272	CcSEcCtD
Apixaban—Drug hypersensitivity—Capecitabine—colon cancer	0.0014	0.0272	CcSEcCtD
Apixaban—Menorrhagia—Vincristine—colon cancer	0.00117	0.0227	CcSEcCtD
Apixaban—Haematoma—Capecitabine—colon cancer	0.000896	0.0174	CcSEcCtD
Apixaban—Blood bilirubin increased—Irinotecan—colon cancer	0.00089	0.0173	CcSEcCtD
Apixaban—Haematemesis—Capecitabine—colon cancer	0.000811	0.0158	CcSEcCtD
Apixaban—F10—vagina—colon cancer	0.000807	0.0651	CbGeAlD
Apixaban—Metrorrhagia—Capecitabine—colon cancer	0.000789	0.0154	CcSEcCtD
Apixaban—Haemoptysis—Capecitabine—colon cancer	0.000761	0.0148	CcSEcCtD
Apixaban—Vaginal haemorrhage—Capecitabine—colon cancer	0.000761	0.0148	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.000702	0.0137	CcSEcCtD
Apixaban—Petechiae—Capecitabine—colon cancer	0.000685	0.0133	CcSEcCtD
Apixaban—F10—liver—colon cancer	0.000681	0.0549	CbGeAlD
Apixaban—CYP2J2—vagina—colon cancer	0.000662	0.0534	CbGeAlD
Apixaban—Contusion—Capecitabine—colon cancer	0.000646	0.0126	CcSEcCtD
Apixaban—Rectal haemorrhage—Capecitabine—colon cancer	0.000624	0.0121	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.000611	0.0119	CcSEcCtD
Apixaban—Haematemesis—Methotrexate—colon cancer	0.000604	0.0117	CcSEcCtD
Apixaban—Blood bilirubin increased—Capecitabine—colon cancer	0.000596	0.0116	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.000585	0.0114	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000565	0.011	CcSEcCtD
Apixaban—CYP2J2—liver—colon cancer	0.000558	0.045	CbGeAlD
Apixaban—Melaena—Capecitabine—colon cancer	0.00055	0.0107	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00055	0.0107	CcSEcCtD
Apixaban—F10—lymph node—colon cancer	0.000522	0.0421	CbGeAlD
Apixaban—Petechiae—Methotrexate—colon cancer	0.00051	0.00992	CcSEcCtD
Apixaban—Ecchymosis—Capecitabine—colon cancer	0.000509	0.00991	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00047	0.00915	CcSEcCtD
Apixaban—Diabetes mellitus—Capecitabine—colon cancer	0.00047	0.00915	CcSEcCtD
Apixaban—Urinary tract disorder—Vincristine—colon cancer	0.000429	0.00834	CcSEcCtD
Apixaban—Connective tissue disorder—Vincristine—colon cancer	0.000426	0.0083	CcSEcCtD
Apixaban—Urethral disorder—Vincristine—colon cancer	0.000425	0.00828	CcSEcCtD
Apixaban—Epistaxis—Fluorouracil—colon cancer	0.000425	0.00828	CcSEcCtD
Apixaban—Haemoglobin—Irinotecan—colon cancer	0.000425	0.00827	CcSEcCtD
Apixaban—Haemorrhage—Irinotecan—colon cancer	0.000423	0.00823	CcSEcCtD
Apixaban—Connective tissue disorder—Irinotecan—colon cancer	0.000415	0.00809	CcSEcCtD
Apixaban—Melaena—Methotrexate—colon cancer	0.00041	0.00797	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000409	0.00796	CcSEcCtD
Apixaban—Haemoglobin—Fluorouracil—colon cancer	0.000407	0.00792	CcSEcCtD
Apixaban—Haemorrhage—Fluorouracil—colon cancer	0.000405	0.00788	CcSEcCtD
Apixaban—Angiopathy—Vincristine—colon cancer	0.000394	0.00766	CcSEcCtD
Apixaban—Mediastinal disorder—Vincristine—colon cancer	0.000391	0.00761	CcSEcCtD
Apixaban—Angiopathy—Irinotecan—colon cancer	0.000383	0.00746	CcSEcCtD
Apixaban—Immune system disorder—Irinotecan—colon cancer	0.000382	0.00743	CcSEcCtD
Apixaban—Mediastinal disorder—Irinotecan—colon cancer	0.000381	0.00742	CcSEcCtD
Apixaban—Ecchymosis—Methotrexate—colon cancer	0.000379	0.00738	CcSEcCtD
Apixaban—ABCB1—blood vessel—colon cancer	0.000378	0.0305	CbGeAlD
Apixaban—Liver function test abnormal—Capecitabine—colon cancer	0.000378	0.00735	CcSEcCtD
Apixaban—Breast disorder—Capecitabine—colon cancer	0.00037	0.00719	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000368	0.00717	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000361	0.00702	CcSEcCtD
Apixaban—CYP2C8—renal system—colon cancer	0.000356	0.0287	CbGeAlD
Apixaban—Diabetes mellitus—Methotrexate—colon cancer	0.00035	0.00681	CcSEcCtD
Apixaban—Anaemia—Vincristine—colon cancer	0.000349	0.0068	CcSEcCtD
Apixaban—Anaemia—Irinotecan—colon cancer	0.00034	0.00662	CcSEcCtD
Apixaban—CYP2C19—digestive system—colon cancer	0.000335	0.027	CbGeAlD
Apixaban—CYP1A2—renal system—colon cancer	0.000333	0.0269	CbGeAlD
Apixaban—Syncope—Irinotecan—colon cancer	0.00033	0.00642	CcSEcCtD
Apixaban—Anaemia—Fluorouracil—colon cancer	0.000326	0.00634	CcSEcCtD
Apixaban—Loss of consciousness—Irinotecan—colon cancer	0.000323	0.0063	CcSEcCtD
Apixaban—CYP3A5—renal system—colon cancer	0.000321	0.0259	CbGeAlD
Apixaban—Anaphylactic shock—Vincristine—colon cancer	0.000308	0.006	CcSEcCtD
Apixaban—Nervous system disorder—Vincristine—colon cancer	0.000302	0.00589	CcSEcCtD
Apixaban—Thrombocytopenia—Vincristine—colon cancer	0.000302	0.00588	CcSEcCtD
Apixaban—Haematuria—Capecitabine—colon cancer	0.0003	0.00585	CcSEcCtD
Apixaban—Anaphylactic shock—Irinotecan—colon cancer	0.0003	0.00585	CcSEcCtD
Apixaban—Hepatobiliary disease—Capecitabine—colon cancer	0.000298	0.0058	CcSEcCtD
Apixaban—Epistaxis—Capecitabine—colon cancer	0.000297	0.00579	CcSEcCtD
Apixaban—CYP2C19—vagina—colon cancer	0.000296	0.0238	CbGeAlD
Apixaban—Shock—Irinotecan—colon cancer	0.000295	0.00575	CcSEcCtD
Apixaban—Nervous system disorder—Irinotecan—colon cancer	0.000294	0.00573	CcSEcCtD
Apixaban—Thrombocytopenia—Irinotecan—colon cancer	0.000294	0.00572	CcSEcCtD
Apixaban—Hypotension—Vincristine—colon cancer	0.000288	0.00561	CcSEcCtD
Apixaban—Anaphylactic shock—Fluorouracil—colon cancer	0.000288	0.0056	CcSEcCtD
Apixaban—Haemoglobin—Capecitabine—colon cancer	0.000284	0.00553	CcSEcCtD
Apixaban—Haemorrhage—Capecitabine—colon cancer	0.000283	0.00551	CcSEcCtD
Apixaban—Nervous system disorder—Fluorouracil—colon cancer	0.000282	0.00549	CcSEcCtD
Apixaban—Thrombocytopenia—Fluorouracil—colon cancer	0.000282	0.00548	CcSEcCtD
Apixaban—Liver function test abnormal—Methotrexate—colon cancer	0.000281	0.00547	CcSEcCtD
Apixaban—Hypotension—Irinotecan—colon cancer	0.000281	0.00546	CcSEcCtD
Apixaban—Urinary tract disorder—Capecitabine—colon cancer	0.000279	0.00544	CcSEcCtD
Apixaban—Connective tissue disorder—Capecitabine—colon cancer	0.000278	0.00541	CcSEcCtD
Apixaban—Urethral disorder—Capecitabine—colon cancer	0.000277	0.0054	CcSEcCtD
Apixaban—Breast disorder—Methotrexate—colon cancer	0.000275	0.00535	CcSEcCtD
Apixaban—CYP1A2—digestive system—colon cancer	0.000273	0.0221	CbGeAlD
Apixaban—Hypotension—Fluorouracil—colon cancer	0.000269	0.00523	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vincristine—colon cancer	0.000266	0.00518	CcSEcCtD
Apixaban—Eye disorder—Capecitabine—colon cancer	0.000264	0.00515	CcSEcCtD
Apixaban—CYP3A5—digestive system—colon cancer	0.000264	0.0213	CbGeAlD
Apixaban—ABCG2—bone marrow—colon cancer	0.000262	0.0211	CbGeAlD
Apixaban—CYP2C9—digestive system—colon cancer	0.00026	0.0209	CbGeAlD
Apixaban—Gastrointestinal disorder—Irinotecan—colon cancer	0.000259	0.00505	CcSEcCtD
Apixaban—CYP2C8—vagina—colon cancer	0.000258	0.0208	CbGeAlD
Apixaban—Angiopathy—Capecitabine—colon cancer	0.000257	0.005	CcSEcCtD
Apixaban—Immune system disorder—Capecitabine—colon cancer	0.000256	0.00497	CcSEcCtD
Apixaban—Mediastinal disorder—Capecitabine—colon cancer	0.000255	0.00496	CcSEcCtD
Apixaban—ABCG2—vagina—colon cancer	0.000251	0.0202	CbGeAlD
Apixaban—CYP2C19—liver—colon cancer	0.000249	0.0201	CbGeAlD
Apixaban—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000248	0.00483	CcSEcCtD
Apixaban—CYP3A4—renal system—colon cancer	0.000241	0.0195	CbGeAlD
Apixaban—CYP3A5—vagina—colon cancer	0.000233	0.0188	CbGeAlD
Apixaban—Anaemia—Capecitabine—colon cancer	0.000228	0.00443	CcSEcCtD
Apixaban—Hypersensitivity—Vincristine—colon cancer	0.000227	0.00442	CcSEcCtD
Apixaban—ABCB1—embryo—colon cancer	0.000226	0.0182	CbGeAlD
Apixaban—Haematuria—Methotrexate—colon cancer	0.000224	0.00435	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—colon cancer	0.000222	0.00432	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—colon cancer	0.000221	0.00431	CcSEcCtD
Apixaban—Hypersensitivity—Irinotecan—colon cancer	0.000221	0.00431	CcSEcCtD
Apixaban—Syncope—Capecitabine—colon cancer	0.000221	0.0043	CcSEcCtD
Apixaban—CYP2C8—liver—colon cancer	0.000218	0.0176	CbGeAlD
Apixaban—Loss of consciousness—Capecitabine—colon cancer	0.000216	0.00421	CcSEcCtD
Apixaban—Hypersensitivity—Fluorouracil—colon cancer	0.000212	0.00412	CcSEcCtD
Apixaban—Haemoglobin—Methotrexate—colon cancer	0.000212	0.00412	CcSEcCtD
Apixaban—ABCG2—liver—colon cancer	0.000212	0.0171	CbGeAlD
Apixaban—Haemorrhage—Methotrexate—colon cancer	0.000211	0.0041	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000208	0.00405	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—colon cancer	0.000208	0.00405	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—colon cancer	0.000206	0.00402	CcSEcCtD
Apixaban—Dizziness—Vincristine—colon cancer	0.000204	0.00397	CcSEcCtD
Apixaban—CYP1A2—liver—colon cancer	0.000204	0.0164	CbGeAlD
Apixaban—Dizziness—Irinotecan—colon cancer	0.000199	0.00387	CcSEcCtD
Apixaban—CYP3A4—digestive system—colon cancer	0.000198	0.016	CbGeAlD
Apixaban—Shock—Capecitabine—colon cancer	0.000198	0.00385	CcSEcCtD
Apixaban—Nervous system disorder—Capecitabine—colon cancer	0.000197	0.00384	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—colon cancer	0.000197	0.00383	CcSEcCtD
Apixaban—Thrombocytopenia—Capecitabine—colon cancer	0.000197	0.00383	CcSEcCtD
Apixaban—CYP3A5—liver—colon cancer	0.000196	0.0158	CbGeAlD
Apixaban—Skin disorder—Capecitabine—colon cancer	0.000195	0.0038	CcSEcCtD
Apixaban—Rash—Vincristine—colon cancer	0.000194	0.00378	CcSEcCtD
Apixaban—Dermatitis—Vincristine—colon cancer	0.000194	0.00378	CcSEcCtD
Apixaban—CYP2C9—liver—colon cancer	0.000193	0.0156	CbGeAlD
Apixaban—Angiopathy—Methotrexate—colon cancer	0.000191	0.00372	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—colon cancer	0.00019	0.0037	CcSEcCtD
Apixaban—Dizziness—Fluorouracil—colon cancer	0.00019	0.0037	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—colon cancer	0.00019	0.00369	CcSEcCtD
Apixaban—Rash—Irinotecan—colon cancer	0.000189	0.00369	CcSEcCtD
Apixaban—Dermatitis—Irinotecan—colon cancer	0.000189	0.00368	CcSEcCtD
Apixaban—Hypotension—Capecitabine—colon cancer	0.000188	0.00366	CcSEcCtD
Apixaban—ABCB1—epithelium—colon cancer	0.000184	0.0149	CbGeAlD
Apixaban—Nausea—Vincristine—colon cancer	0.000183	0.00357	CcSEcCtD
Apixaban—Rash—Fluorouracil—colon cancer	0.000181	0.00353	CcSEcCtD
Apixaban—Dermatitis—Fluorouracil—colon cancer	0.000181	0.00353	CcSEcCtD
Apixaban—Nausea—Irinotecan—colon cancer	0.000178	0.00347	CcSEcCtD
Apixaban—Gastrointestinal disorder—Capecitabine—colon cancer	0.000174	0.00338	CcSEcCtD
Apixaban—Nausea—Fluorouracil—colon cancer	0.000171	0.00333	CcSEcCtD
Apixaban—ABCB1—renal system—colon cancer	0.000171	0.0138	CbGeAlD
Apixaban—Anaemia—Methotrexate—colon cancer	0.000169	0.0033	CcSEcCtD
Apixaban—ABCG2—lymph node—colon cancer	0.000162	0.0131	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000155	0.00302	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—colon cancer	0.00015	0.00291	CcSEcCtD
Apixaban—Hypersensitivity—Capecitabine—colon cancer	0.000148	0.00288	CcSEcCtD
Apixaban—CYP3A4—liver—colon cancer	0.000147	0.0119	CbGeAlD
Apixaban—Nervous system disorder—Methotrexate—colon cancer	0.000147	0.00286	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—colon cancer	0.000146	0.00285	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—colon cancer	0.000145	0.00283	CcSEcCtD
Apixaban—ABCB1—lymphoid tissue—colon cancer	0.000142	0.0114	CbGeAlD
Apixaban—ABCB1—digestive system—colon cancer	0.00014	0.0113	CbGeAlD
Apixaban—Hypotension—Methotrexate—colon cancer	0.00014	0.00272	CcSEcCtD
Apixaban—Dizziness—Capecitabine—colon cancer	0.000133	0.00259	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—colon cancer	0.000129	0.00251	CcSEcCtD
Apixaban—ABCB1—bone marrow—colon cancer	0.000129	0.0104	CbGeAlD
Apixaban—Rash—Capecitabine—colon cancer	0.000127	0.00247	CcSEcCtD
Apixaban—Dermatitis—Capecitabine—colon cancer	0.000127	0.00246	CcSEcCtD
Apixaban—ABCB1—vagina—colon cancer	0.000124	0.00998	CbGeAlD
Apixaban—Nausea—Capecitabine—colon cancer	0.000119	0.00232	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—colon cancer	0.00011	0.00215	CcSEcCtD
Apixaban—ABCB1—liver—colon cancer	0.000104	0.00842	CbGeAlD
Apixaban—Dizziness—Methotrexate—colon cancer	9.89e-05	0.00193	CcSEcCtD
Apixaban—Rash—Methotrexate—colon cancer	9.43e-05	0.00184	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—colon cancer	9.42e-05	0.00183	CcSEcCtD
Apixaban—Nausea—Methotrexate—colon cancer	8.89e-05	0.00173	CcSEcCtD
Apixaban—ABCB1—lymph node—colon cancer	8e-05	0.00646	CbGeAlD
